Highest-materiality recent filing
QT Imaging closes $10M public offering of 1.2M shares and pre-funded warrants
Offered 1,200,000 shares at $5.00/share and 800,000 pre-funded warrants at $4.9999; gross proceeds $10M, net ~$9M.
QT Imaging Q1 revenue $6.5M (+133% YoY); net loss $3.4M; reaffirms FY2026 guidance ~$39M
Revenue of $6.5M up 133% YoY on 13 scanners shipped (vs. 6 in Q1 2025).
QT Imaging beats 2025 revenue guidance at $18.9M; guides FY2026 to $39M
Revenue $18.9M, +288% YoY, above $18M guidance; Q4 rev $8.3M (+877% YoY) on 17 scanners shipped.
QT Imaging reports Q4 record revenue $8.3M (+877% YoY); 2025 revenue $18.9M, beats guidance
Q4 revenue $8.3M, up 97% QoQ and 877% YoY; record 17 scanners shipped.
QT Imaging FY2024 revenue rises to $4.88M; net loss widens to $8.98M
Revenue surged to $4,878,665 from $40,355 in 2023, driven by new distribution agreement.
QT Imaging signs exclusive UAE distribution deal; minimum $24M revenue from 43 scanners
Exclusive agreement with Al Naghi Medical for QT Breast Acoustic CT and QTI Cloud Platform in UAE.
QT Imaging Q3 revenue $4.2M (+339% YoY); raises 2026 outlook to $39M; applies for Nasdaq relisting
Q3 revenue $4.2M, up 15% sequentially from Q2 2025; shipped 9 scanners.
QT Imaging approves 3:1 reverse stock split, applies to relist on Nasdaq
Board fixed reverse split at 3:1, effective 4:01 PM ET Oct 23, 2025; shares reduce from ~35.7M to ~11.9M.
QT Imaging raises ~$18M in PIPE financing to fund growth and repay debt; plans NASDAQ relisting
Gross proceeds ~$18.18M from sale of 12,120,798 shares (or pre-funded warrants) at $1.50/share plus warrants.
QT Imaging repurchases Yorkville warrants for $5M, appoints new CFO Jay Jennings
Repurchased 15M-share Yorkville warrant for $5M; funded by new $5M Lynrock Lake loan, raising total debt to $15.1M.
QT Imaging enters exclusive distribution agreement with Gulf Medical for Saudi Arabia
QT Imaging grants Gulf Medical exclusive rights to market and sell Breast Acoustic CT scanners and QTI Cloud Platform subscriptions in Saudi Arabia.
QT Imaging Q2 revenue surges 113% YoY to $3.7M; pursues Nasdaq uplisting
Q2 2025 revenue $3.7M, up 113% from Q2 2024 and 31% from Q1 2025; gross margin 50%.
Amends Lynrock Lake warrant (61M shares, $0.40 strike) to protect holder in Cash/Public Acquisition, automatically cashless exercised.
QT Imaging Q1 revenue $2.8M, 65% gross margin; net loss $11.1M
Revenue $2.8M (65% gross margin), up from $1.4M YoY; shipped 6 scanners vs 3 in Q1 2024.
QT Imaging delisted from Nasdaq, trades on OTCQB; raises $500K in insider PIPE
Delisting proceedings initiated by Nasdaq; stock suspended Jan 28, 2025 and now trades OTCQB (QTIH).
FY 2024 commercial revenue $4.9M vs <$0.1M in 2023; 12 QT Breast Acoustic CT scanners shipped at 54% gross margin.
QTI secures $10.1M Lynrock Lake loan, retires Yorkville note, issues 61M warrants
New $10.1M senior secured term loan from Lynrock Lake at 10% interest, matures March 2027.
QT Imaging delisted from Nasdaq; shares move to OTC under QTIH
Nasdaq Hearings Panel denied appeal on Jan 24, 2025; suspension effective Jan 28, 2025.
QT Imaging amends notes with YA II PN and Funicular; lowers conversion price, extends maturity
YA II PN note: conversion price lowered to $0.584/share for $1.5M of $8.34M principal; remainder stays at $4.61395.
QT Imaging fails to regain Nasdaq bid price compliance; delisting appeal pending
Nasdaq staff notified QT Imaging on Dec 17, 2024 that it failed to regain bid price compliance by Dec 16, 2024.
Generated $0.9M scanner sales revenue with 65% gross margin in Q3 2024.
QT Imaging receives Nasdaq delisting notice; plans to appeal by Nov 13, 2024
Nasdaq notified QT Imaging on Nov 6, 2024 of delisting proceedings due to failure to maintain $50M market value of listed securities.
QT Imaging amends $10M convertible note: maturity extended to Mar 2026, floor price cut to $0.50
Maturity of $10M convertible note extended from Dec 15, 2025 to Mar 31, 2026.
QT Imaging enters Omnibus Amendment with YA II PN to extend note maturity and modify payment terms
Maturity date of $10M convertible note extended from June 4, 2025 to December 15, 2025.
QT Imaging triggers accelerated payments under Yorkville note; first payment $1.52M
Floor Price Trigger on Sep 11, 2024: daily VWAP below $0.8768 for five trading days.
QT Imaging receives Nasdaq MVPHS deficiency notice; third listing standard now in violation
Market Value of Publicly Held Securities below $15M minimum for 31 consecutive business days.
QT Imaging Q2 2024 revenue $1.7M, 51% gross margin; partners with OU cancer center
Revenue of $1.7M in Q2 2024, up from $1.4M in Q1 2024 and <$0.1M in Q2 2023.
QT Imaging enters exclusive U.S. distribution deal with Canon subsidiary NXC Imaging
NXC appointed exclusive reseller for QT Imaging equipment in U.S. and territories, replacing prior Sales Agent Agreement.
QT Imaging receives Nasdaq minimum bid price deficiency notice; faces delisting risk
Nasdaq notified QT Imaging on June 17, 2024 that bid price is below $1.00 for 30 consecutive business days.
On March 18, 2024, Gerald McMorrow informed the board of directors (the “ Board ”) of QT Imaging Holdings, Inc. (the “ Company ”) that he is resigning from his position as a Class I director of the Company, effective as of March 18, 2024.
On March 21, 2024, the Board appointed James Greene to serve as a Class I director.
On March 12, 2024, the board of directors (the “ Board ”) of QT Imaging Holdings, Inc. (the “ Company ”) terminated Dr. John C. Klock from his position as Chief Executive Officer effective as of March 12, 2024.
On March 12, 2024, the Board appointed Dr. Raluca Dinu, who is also a member of the Board, to be employed as its Acting Chief Executive Officer effective as of March 12, 2024.
The following persons are serving as executive officers and directors of the Company upon the Closing, with Dr. John Klock and Stas Budagov having been named as executive officers effective upon the Closing on March 4, 2024, and each of the directors having been elected by the GigCapital5 stockholders to the board also upon the Closing on March 4, 2024.
The following persons are serving as executive officers and directors of the Company upon the Closing, with Dr. John Klock and Stas Budagov having been named as executive officers effective upon the Closing on March 4, 2024, and each of the directors having been elected by the GigCapital5 stockholders to the board also upon the Closing on March 4, 2024.
The following persons are serving as executive officers and directors of the Company upon the Closing, with Dr. John Klock and Stas Budagov having been named as executive officers effective upon the Closing on March 4, 2024, and each of the directors having been elected by the GigCapital5 stockholders to the board also upon the Closing on March 4, 2024.
Effective upon the Closing on February 28, 2024, Dr. Raluca Dinu and Brad Weightman resigned as executive officers of GigCapital5, and each of Raanan S. Horowitz, Karen Rogge, and Dorothy Hayes, following their not standing for re-election to the Board, resigned as directors of GigCapital5.
The following persons are serving as executive officers and directors of the Company upon the Closing, with Dr. John Klock and Stas Budagov having been named as executive officers effective upon the Closing on March 4, 2024, and each of the directors having been elected by the GigCapital5 stockholders to the board also upon the Closing on March 4, 2024.
The following persons are serving as executive officers and directors of the Company upon the Closing, with Dr. John Klock and Stas Budagov having been named as executive officers effective upon the Closing on March 4, 2024, and each of the directors having been elected by the GigCapital5 stockholders to the board also upon the Closing on March 4, 2024.
Effective upon the Closing on February 28, 2024, Dr. Raluca Dinu and Brad Weightman resigned as executive officers of GigCapital5, and each of Raanan S. Horowitz, Karen Rogge, and Dorothy Hayes, following their not standing for re-election to the Board, resigned as directors of GigCapital5.
The following persons are serving as executive officers and directors of the Company upon the Closing, with Dr. John Klock and Stas Budagov having been named as executive officers effective upon the Closing on March 4, 2024, and each of the directors having been elected by the GigCapital5 stockholders to the board also upon the Closing on March 4, 2024.
Max materiality 0.90 · Median 0.60 · Most common event other_material